96
RESPIRATORY FAILURE and ARDS By Laurie Dickson

By Laurie Dickson. Respiration Exchange of O2 and CO2 gas exchange Respiratory Failure the inability of the cardiac and pulmonary systems to maintain

Embed Size (px)

Citation preview

  • Slide 1

By Laurie Dickson Slide 2 Respiration Exchange of O2 and CO2 gas exchange Respiratory Failure the inability of the cardiac and pulmonary systems to maintain an adequate exchange of oxygen and CO2 in the lungs Slide 3 Slide 4 Slide 5 Hypoxemic Respiratory Failure- (Affects the pO2) Causes- 4 Physiologic Mechanisms 1. V/Q Mismatch 2. Shunt 3. Diffusion Limitation 4. Alveolar Hypoventilation- CO2 andPO2 Slide 6 VentilationPerfusion Mismatch (V/Q) Normal V/Q =1 (1ml air/ 1ml of blood) Ventilation=lungs Perfusion or Q=perfusion Slide 7 Pulmonary Embolus Pulmonary Embolus- (VQ scan) Slide 8 Shunt Anatomic Intrapulmonary blood passes through an anatomic channel of the heart and does not pass through the lungs ex: ventricular septal defect blood flows through pulmonary capillaries without participating in gas exchange ex: alveoli filled with fluid * Patients with shunts are more hypoxemic than those with VQ mismatch and they may require mechanical ventilators Slide 9 Diffusion Limitation Gas exchange is compromised by a process that thickens or destroys the membrane 1. Pulmonary fibrosis 2. 2. ARDS * A classic sign of diffusion limitation is hypoxemia during exercise but not at rest Slide 10 Alveolar Hypoventilation Mainly due to hypercapnic respiratory failure but can cause hypoxemia Increased pCO2 with decreased PO2 Restrictive lung disease CNS diseases Chest wall dysfunction Neuromuscular diseases Slide 11 Hypercapnic Respiratory Failure Failure of Ventilation PaCO2>45 mmHg in combination with acidemia (arterial pH< 7.35) Caused by conditions that keep the air in Slide 12 Hypercapnic Respiratory Failure Abnormalities of the: Airways and Alveoli-air flow obstruction and air trapping Asthma, COPD, and cystic fibrosis CNS-suppresses drive to breathe drug OD, narcotics, head injury, spinal cord injury Chest wall-Restrict chest movement Flail chest, morbid obesity, kyphoscoliosis Neuromuscular Conditions- respiratory muscles are weakened: Guillain-Barre, muscular dystrophy, myasthenia gravis and multiple sclerosis Slide 13 Tissue Oxygen needs Tissue O2 delivery is determined by: Amount of O2 in hemoglobin Cardiac output *Respiratory failure places patient at more risk if cardiac problems or anemia Slide 14 Signs and Symptoms of Respiratory Failure hypoxemia pO245-50 only one cause- hypoventilation *In patients with COPD watch for acute drop in pO2 and O2 sats along with inc. C02 Slide 15 Specific Clinical Manifestations Respirations- depth and rate Patient position- tripod position Pursed lip breathing Orthopnea Inspiratory to expiratory ratio (normal 1:2) Retractions and use of accessory muscles Breath sounds Slide 16 Hypoxemia Tachycardia and Hypertension to comp. Dyspnea and tachypnea to comp. Cyanosis Restlessness and apprehension Confusion and impaired judgment Later dysrhythmias and metabolic acidosis, decreased B/P and CO. Slide 17 Hypercapnia Dyspnea to respiratory depression- if too high CO2 narcosis Headache-vasodilation Papilledema Tachycardia and inc. B/P Drowsiness and coma Respiratory acidosis **Administering O2 may eliminate drive to breathe especially with COPD patients Slide 18 Diagnosis Physical Assessment Pulse oximetry ABG CXR CBC Electrolytes EKG Sputum and blood cultures, UA V/Q scan if ?pulmonary embolus Pulmonary function tests Slide 19 Treatment Goal- to correct Hypoxia O2 therapy Mobilization of secretions Positive pressure ventilation(PPV) Noninvasively( NIPPV) through mask Invasively through oro or nasotracheal intubation Slide 20 O2 Therapy If secondary to V/Q mismatch- 1-3Ln/c or 24%- 32% by mask If secondary to intrapulmonary shunt- positive pressure ventilation-PPV May be via ET tube Tight fitting mask Goal is PaO2 of 55-60 with SaO2 at 90% or more at lowest O2 concentration possible O2 at high concentrations for longer than 48 hours causes O2 toxicity Slide 21 Mobilization of secretions Effective coughing quad cough, huff cough, staged cough Positioning- HOB 45 degrees or recliner chair or bed Good lung down Hydration fluid intake 2-3 L/day Humidification- aerosol treatments- mucolytic agents Chest PT- postural drainage, percussion and vibration Airway suctioning Slide 22 Positive Pressure Ventilation Noninvasive ( NIPPV) through mask Used for acute and chronic resp failure BiPAP- different levels of pressure for inspiration and expiration- (IPAP) higher for inspiration,(EPAP) lower for expiration CPAP- for sleep apnea Used best in chronic resp failure in patients with chest wall and neuromuscular disease, also with HF and COPD. NPPV Slide 23 Endotracheal Tube Fig. 66-17 Endotracheal intubation Slide 24 Tracheostomy Surgical procedure Used when need for artificial airway is expected to be long term Research shows benefit to early trach Slide 25 Exhaled C02 (ETC02) normal 35-45 Used when trying to wean patient from a ventilator Slide 26 Drug Therapy Relief of bronchospasm- Bronchodilators metaproterenol (Alupent) and albuterol-(Ventolin, Proventil, Proventil-HFA, AccuNeb, Vospire, ProAir ) Watch for what side effect? Reduction of airway inflammation corticosteroids by inhalation or IV or po Reduction of pulmonary congestion- diuretics and nitroglycerine with heart failure Slide 27 Drug Therapy Treatment of pulmonary infections- IV antibiotics- vancomycin and ceftriaxone (Rocephin) Reduction of anxiety, pain and agitation propofol (Diprivan), lorazepam (Ativan), midazolam (Versed), opioids May need sedation or neuromuscular blocking agent if on ventilator vecuronium (Norcuron), cisatracurium besylate (Nimbex ) assess with peripheral nerve stim. Slide 28 Medical Supportive Treatment Treat underlying cause Maintain adequate cardiac output- monitor B/P and MAP. **Need B/P of 90 systolic and MAP of 60 to maintain perfusion to the vital organs Maintain adequate Hemoglobin concentration- need 9g/dl or greater Nutrition- During acute phase- enteral or parenteral nurtition In a hypermetabolic state- need more calories If retain CO2- avoid high carb diet Slide 29 Acute Respiratory Failure Gerontologic Considerations Physiologic aging results in Ventilatory capacity Alveolar dilation Larger air spaces Loss of surface area Diminished elastic recoil Decreased respiratory muscle strength Chest wall compliance Slide 30 a variety of acute and diffuse infiltrative lesions which cause severe refractory arterial hypoxemia and life-threatening arrhythmias Slide 31 Memory Jogger A ssault to the pulmonary system R espiratory distress D ecreased lung compliance S evere respiratory failure Slide 32 150,000 adults develop ARDS About 50% survive Patients with gram negative septic shock and ARDS have mortality rate of 70-90% Slide 33 Direct Causes Inflammatory process is involved Pneumonia* Aspiration of gastric contents* Pulmonary contusion Near drowning Inhalation injury Slide 34 Indirect Causes Inflammatory process is involved Sepsis* (most common) gm - Severe trauma with shock state that requires multiple blood transfusions* Drug overdose Acute pancreatitis Slide 35 Slide 36 *Causes (see notes) DIFFUSE lung injury (SIRS or MODS) Damage to alveolar capillary membrane Pulmonary capillary leak Interstitial & alveolar edema Inactivation of surfactant Alveolar atalectasis CO Metabolic acidosis CO Severe & refractory hypoxemia Hypoventilation Hypercapnea Respiratory Acidosis Hyperventilation Hypocapnea Respiratory Alkalosis SHUNTING Stiff lungs Slide 37 Pathophysiology of ARDS Damage to alveolar-capillary membrane Increased capillary hydrostatic pressure Decreased colloidal osmotic pressure Interstitial edema Alveolar edema or pulmonary edema Loss of surfactant Slide 38 Slide 39 Pathophysiologic Stages in ARDS Injury or Exudative- 1-7 days Interstitial and alveolar edema and atelectasis Refractory hypoxemia and stiff lungs Reparative or Proliferative-1-2 weeks after Dense fibrous tissue, increased PVR and pulmonary hypertension occurs Fibrotic-2-3 week after Diffuse scarring and fibrosis, decreased surface area, decreased compliance and pulmonary hypertension Slide 40 The essential disturbances of ARDS Interstitial and alveolar edema and atelectasis Progressive arterial hypoxemia in spite of inc. O2 is hallmark of ARDS Slide 41 Clinical Manifestations: Early Dyspnea-(almost always present), tachypnea, cough, restlessness Lung sounds-may be normal or reveal fine, scattered crackles ABGs -Mild hypoxemia and respiratory alkalosis caused by hyperventilation Chest x-ray -may be normal or show minimal scattered interstitial infiltrates Edema -may not show until 30% increase in lung fluid content Slide 42 Clinical Manifestations: Late Symptoms worsen with progression of fluid accumulation and decreased lung compliance PFTs show decreased compliance and lung volume Evident discomfort and increased WOB Suprasternal retractions Tachycardia, Diaphoresis Changes in sensorium with decreased mentation, cyanosis, and pallor Hypoxemia and a PaO 2 /FIO 2 ratioSlide 43 Clinical Manifestations As ARDS progresses, profound respiratory distress requires endotracheal intubation and positive pressure ventilation Chest x-ray termed whiteout or white lung because of consolidation and widespread infiltrates throughout lungs Slide 44 Clinical Manifestations If prompt therapy not initiated, severe hypoxemia, hypercapnia, and metabolic acidosis may ensue Slide 45 Nursing Diagnoses Ineffective airway clearance Ineffective breathing pattern Risk for fluid volume imbalance Anxiety Impaired gas exchange Imbalanced nutrition Slide 46 Planning Following recovery PaO 2 within normal limits or at baseline SaO 2 > 90% Patent airway Clear lungs or auscultation Slide 47 ARDS Diagnosis Progressive hypoxemia due to shunting Decreased lung compliance Bilateral diffuse lung infiltrate Slide 48 Nursing Assessment Lung sounds ABGs CXR Capillary refill Neuro assessment Vital signs O2 sats Hemodynamic monitoring values The Auscultation Assistant - Breath Sounds Slide 49 Diagnostic Tests ABG CXR Pulmonary Function Tests Hemodynamic Monitoring ABG review RealNurseEd (Education for Real Nurses by a Real Nurse) Slide 50 ARDSSevere ARDS Slide 51 Goal of Treatment for ARDS Maintain adequate ventilation and respirations. Prevent injury Manage anxiety Slide 52 Treatment Mechanical Ventilation- goal PO2>60 and O2 sat 90% with FIO2 < 50 PEEP- can cause CO + B/P and barotrauma Positioning- prone, continuous lateral rotation therapy and kinetic therapy Hemodynamic Monitoring- fluid replacement or diuretics Crystalloids vs Colloids Enteral or Parenteral Feeding- high calorie, high fat. Slide 53 PEEP Cannot expire completely. Causes alveoli to remain inflated Peep Peep Complications can include decreased cardiac output, pneumothorax, and increased intracranial pressure Slide 54 Slide 55 Proning typically reserved for refractory hypoxemia not responding to other therapies Plan for immediate repositioning for cardiopulmonary resuscitation *** Slide 56 Proning Mediastinal and heart contents place more pressure on lungs when in supine position than when in prone Fluid pools in dependent regions of lung Predisposes to atelectasis With prone position nondependent air-filled alveoli become dependent perfusion becomes greater to air-filled alveoli thereby improving ventilation-perfusion matching. May be sufficient to reduce inspired O 2 or PEEP Slide 57 Benefits to Proning Before proning ABG on 100%O2 7.28/70/70 After proning ABG on 100% 7.37/56/227 Slide 58 Other positioning strategies Kinetic therapy Continuous lateral rotation therapy Slide 59 Oxygen Therapy High flow systems used to maximize O 2 delivery SaO 2 continuously monitored Give lowest concentration that results in PaO 2 60 mm Hg or greater Risk for O 2 toxicity increases when FIO 2 exceeds 60% for more than 48 hours Patients will commonly need intubation with mechanical ventilation because PaO 2 cannot be maintained at acceptable levels Slide 60 Mechanical ventilation PEEP at 5 cm H 2 O compensates for loss of glottic function Opens collapsed alveoli Higher levels of PEEP are often needed to maintain PaO 2 at 60 mm Hg or greater High levels of PEEP can compromise venous return Preload, CO, and BP Slide 61 Medical Supportive Therapy Maintenance of cardiac output and tissue perfusion Continuous hemodynamic monitoring Continuous BP measurement via arterial cath Pulmonary artery catheter to monitor pulmonary artery pressure, pulmonary artery wedge pressures, and CO Administration of crystalloid fluids or colloid fluids, or lower PEEP if CO falls Slide 62 Medical Supportive Therapy Use of inotropic drugs may be necessary Hemoglobin usually kept at levels greater than 9 or 10 with SaO 2 90% Packed RBCs Maintenance of fluid balance May be volume depleted and prone to hypotension and decreased CO from mechanical ventilation and PEEP Monitor PAWP, daily weights, and I and Os to assess fluid status Slide 63 Medical Supportive Therapy Pulmonary Artery Wedge Pressure Pressure in pulmonary artery Indirect estimate of L Arterial pressure Keep as low as possible without imparing cardiac output (normal 6-12) Prevent pulmonary edema PAWP increases with Heart Failure PAWP does not increase with ARDS Slide 64 Other Treatments Inhaled Nitric Oxide Surfactant therapy NSAIDS and Corticosteroids Slide 65 ARDS Prioritization and Critical Thinking Questions #28 When assessing a 22 Y/o client admitted 3 days ago with pulmonary contusions after an MVA, the nurse finds shallow respirations at a rate of 38. The client states he feels dizzy and scared. O2 sat is 80% on 6 Ln/c. which action is most appropriate? A.Inc. flow rate of O2 to 10 L/min and reassess in 10 min. B.Assist client to use IS and splint chest using a pillow as he coughs. C.Adminster ordered MSO4 to client to dec. anxiety and reduce hyperventilation. D.Place client on non-rebreather mask at 100% O2 and call the Dr. Slide 66 #15. After change of shift report, you are assigned to care of the following clients. Which should be assessed first? 68 y/o on ventilator who needs a sterile sputum specimen sent to the lab. 59y/o with COPD and has a pulse ox on previous shift of 90%. 72y/o with pneumonia who needs to be started on IV antibiotics. 51y/o with asthma c/o shortness of breath after using his bronchodilator inhaler. Slide 67 a machine that moves air in and out of the lungs Slide 68 Mechanical Ventilation Indications Apnea or impending inability to breathe Acute respiratory failure pH50 Severe hypoxia pO25 cm H 2 O Slide 85 Complications of PPV Pulmonary System Barotrauma Air can escape into pleural space from alveoli or interstitium Accumulate, and become trapped Pneumothorax Subcutaneous emphysema Patients with compliant lungs are at risk Chest tubes may be placed prophylactically Slide 86 Complications of PPV Ventilator-associated pneumonia (VAP) Pneumonia that occurs 48 hours or more after ET intubation Clinical evidence Fever and/or elevated white blood cell count Purulent or odorous sputum Crackles or rhonchi on auscultation Pulmonary infiltrates on chest x-ray Slide 87 Complications of PPV Guidelines to prevent VAP HOB at least 45 degrees No routine changing of ventilator circuit tubing Use ET that allows continuous suctioning of secretions Drain condensation that collects in ventilator tubing Slide 88 Complicationof PPV Fluid retention Occurs after 48 to 72 hours of PPV, especially PPV with PEEP May be due to cardiac output Results Diminished renal perfusion Release of renin-angiotensin-aldosterone Leads to sodium and water retention Slide 89 Complications of PPV Fluid retention Pressure changes within thorax release of atrial natriuretic peptide (ANP) Causing sodium retention Stress response Antidiuretic hormone and cortisol may be Contributes to sodium and water retention Slide 90 Complications of PPV Musculoskeletal system Maintain muscle strength and prevent problems associated with immobility Progressive ambulation of patients receiving long-term PPV can be attained without interruption of mechanical ventilation Slide 91 Complications of PPV Gastrointestinal system Risk for stress ulcers and GI bleeding Risk of translocation of GI bacteria Cardiac output may contribute to gut ischemia Peptic ulcer prophylaxis Histamine (H 2 )-receptor blockers Proton pump inhibitors Tube feedings Gastric acidity risk of stress ulcer/hemorrhage Slide 92 Mechanical Ventilation Psychosocial needs Physical and emotional stress due to inability to speak, eat, move, or breathe normally Pain, fear, and anxiety related to tubes/ machines Ordinary ADLs are complicated or impossible Slide 93 Psychosocial needs Involve patients in decision making Encourage hope and build trusting relationships with patient and family Provide sedation and/or analgesia to facilitate optimal ventilation If necessary, provide paralysis to achieve more effective synchrony with ventilator and increase oxygenation Paralyzed patient can hear, see, think, feel Sedation and analgesia must always be administered concurrently Slide 94 Alternative modes If hypoxemia persists Pressure support ventilation Pressure release ventilation Pressure control ventilation Inverse ratio ventilation High-frequency ventilation Permissive hypercapnia Independent Lung Ventilation Slide 95 Mechanical Ventilation Extracorporeal membrane oxygenation Alternative form of pulmonary support for patient with severe respiratory failure Modification of cardiopulmonary bypass Involves partially removing blood through use of large- bore catheters, infusing oxygen, removing CO 2, and returning blood back to patient Slide 96 The nurse is assigned to provide nursing care for a client receiving mechanical ventilation. Which action should be delegated to the experienced nursing assistant? A. Assess respiratory status q 4 hours. B. Take VS and pulse ox reading q4 hours. C. Check ventilator settings to make sure they are as prescribed. D.Observe clients need for suctioning q 2 hours.